IRD
Opus Genetics·NASDAQ
--
--(--)
--
--(--)
IRD fundamentals
Opus Genetics (IRD) released its earnings on Aug 13, 2025: revenue was 2.88M (YoY +159.17%), missed estimates; EPS was -0.12 (YoY +60.00%), beat estimates.
Revenue / YoY
2.88M
+159.17%
EPS / YoY
-0.12
+60.00%
Report date
Aug 13, 2025
EPS
Actual | -3.57 | -0.52 | -0.25 | -0.35 | -0.35 | -0.25 | -0.22 | 1.58 | -0.28 | -0.24 | 0.25 | -0.21 | -0.29 | -0.3 | -0.29 | -1.27 | -0.24 | -0.12 | ||
Forecast | -0.7125 | -0.3825 | -0.358 | -0.288 | -0.35 | -0.332 | -0.282 | 1.315 | -0.154 | -0.226 | -0.222 | -0.0525 | -0.11 | -0.255 | -0.2375 | -0.245 | -0.25 | -0.205 | ||
Surprise | 0.00% | 0.00% | -401.05% | -35.95% | +30.17% | -21.53% | 0.00% | +24.70% | +21.99% | +20.15% | -81.82% | -6.19% | +212.61% | -300.00% | -163.64% | -17.65% | -22.11% | -418.37% | +4.00% | +41.46% |
Revenue
Actual | -- | -- | 0 | 100.00K | 489.00K | 0 | 0 | 0 | 0 | 39.85M | 1.75M | 3.67M | 11.94M | 1.69M | 1.71M | 1.11M | 3.87M | 4.30M | 4.37M | 2.88M |
Forecast | -- | -- | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 29.45M | 2.95M | 2.43M | 3.03M | 5.36M | 5.34M | 2.45M | 2.28M | 3.40M | 3.10M | 4.05M |
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | +35.34% | -40.74% | +51.50% | +294.52% | -68.43% | -67.96% | -54.67% | +69.49% | +26.53% | +41.03% | -28.84% |
Earnings Call
You can ask Aime
What were the key takeaways from Opus Genetics’s earnings call?What were the key takeaways from Opus Genetics's earnings call?What does Opus Genetics do and what are its main business segments?What is Opus Genetics's latest dividend and current dividend yield?What is the market's earnings forecast for Opus Genetics next quarter?What factors drove the changes in Opus Genetics's revenue and profit?Did Opus Genetics beat or miss consensus estimates last quarter?What is the revenue and EPS growth rate for Opus Genetics year over year?
